Copper (II) complexes of bidentate ligands exhibit potent anti-cancer activity regardless of platinum sensitivity status

Insensitivity to platinum, either through inherent or acquired resistance, is a major clinical problem in the treatment of many solid tumors. Here, we explored the therapeutic potential of diethyldithiocarbamate (DDC), pyrithione (Pyr), plumbagin (Plum), 8-hydroxyquinoline (8-HQ), clioquinol (CQ) co...

Descripción completa

Detalles Bibliográficos
Autores principales: Wehbe, Mohamed, Lo, Cody, Leung, Ada W. Y., Dragowska, Wieslawa H., Ryan, Gemma M., Bally, Marcel B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Preclinical Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5694505/
https://www.ncbi.nlm.nih.gov/pubmed/28733701
http://dx.doi.org/10.1007/s10637-017-0488-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5694505/
https://www.ncbi.nlm.nih.gov/pubmed/28733701
http://dx.doi.org/10.1007/s10637-017-0488-2

Ejemplares similares